EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies

Yan Chen, Fangfang Zhang, Hong Wu, Yanlin Wang, Yang He, Honggui Zhou, Jing Jiang

Gynecologic and Obstetric Investigation · 06.11.2026

DOI: 10.1159/goi/aczag021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 06.11.2026. Verfasst von Yan Chen und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the clinical outcomes of high-intensity focused ultrasound (HIFU) ablation in patients with different subtypes of adenomyosis as classified by preoperative magnetic resonance imaging (MRI), and to explore the implications for personalized treatment planning.

Design

A retrospective cohort study.

Participants

447 patients with adenomyosis who underwent HIFU treatment were classified according to the Kishi MRI criteria into Type I (intrinsic, n=195), Type II (extrinsic, n=92), Type III (intramural, n=50), and Type IV (full-thickness, n=110).

Methods

All 447 patients underwent HIFU ablation under standardized procedural protocols.Treatment parameters, non-perfused volume (NPV) ratio, relief of dysmenorrhea (assessed by NRS score), and improvement in menstrual blood volume (assessed by FPS score) were analyzed and compared across subtypes at 3 and 6 months post-treatment.

Results

Patients with Type IV adenomyosis had significantly larger lesion volumes and required longer treatment durations with higher energy delivery (p<0.001). The NPV ratio was highest in Type I (74.91% ± 28.34%), followed by Type III (70.34% ± 26.12%), both significantly higher than in Type II (60.01% ± 2.9%) and Type IV (65.93% ± 25.41%) (p<0.05). All subtypes demonstrated significant and sustained improvement in both dysmenorrhea and menorrhagia at follow-up (p<0.05). The comprehensive treatment success rate was highest for Type IV at both 3 (21.82%) and 6 months (27.27%).

Limitations

This study has several limitations. First, the retrospective design inherently introduces selection bias and limits causal inference. Second,long-term follow-up beyond 6 months was not available, precluding assessment of durability of symptom relief and recurrence rates.

Conclusions

High-intensity focused ultrasound (HIFU) provides effective symptom relief for all MRI-classified subtypes of adenomyosis. Treatment parameters and efficacy, however, vary by subtype. MRI classification is therefore crucial for guiding treatment and anticipating technical challenges. A personalized approach based on subtype may further optimize therapeutic outcomes.

Zitieren

APA

Chen, Y., Zhang, F., Wu, H., Wang, Y., He, Y., Zhou, H., & Jiang, J. (2026). MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/goi/aczag021

Vancouver

Chen Y, Zhang F, Wu H, Wang Y, He Y, Zhou H, et al. MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies. Gynecologic and Obstetric Investigation. 2026. doi:10.1159/goi/aczag021

BibTeX
@article{Chen2026,
  author = {Chen, Yan and Zhang, Fangfang and Wu, Hong and Wang, Yanlin and He, Yang and Zhou, Honggui and Jiang, Jing},
  title = {MRI-Based Analysis of Post-HIFU Efficacy in Uterine Adenomyosis and Personalized Treatment Strategies},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2026},
  doi = {10.1159/goi/aczag021}
}
Kostenlos starten →